Monitor for year-end 2026 milestone of 20-amino-acid detection and any updates on Proteus commercial launch timing in Q2 2027. No revenue or earnings data in this filing — next catalyst is likely a business update or quarterly filing.
Price Chart
Executive Summary
Quantum-Si announced it has demonstrated detection of 19 amino acids in its Proteus development program, an incremental technical milestone toward the goal of detecting all 20 amino acids by year-end 2026. The company expects to deploy this capability into a developmental sequencing kit and targets commercial launch of the Proteus platform in Q2 2027. No financial data or guidance was provided.
Key Facts
- Demonstrated detection of 19 amino acids in Proteus development program
- Working to deploy 19-amino-acid detection into a developmental sequencing kit
- Confident in demonstrating detection of all 20 amino acids by year-end 2026
- Proteus platform commercial launch targeted for Q2 2027
- Press release dated October 8, 2026
Financial Impact
No financial figures provided; pre-revenue development-stage company
Risk Factors
- Failure to demonstrate detection of all 20 amino acids by year-end 2026
- Delays in deploying 19-amino-acid capability into a developmental sequencing kit
- Commercial launch of Proteus may slip beyond Q2 2027
- Pre-revenue company with no financial data in this filing
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001816431-26-000064 |
| Document: a19aadetectionpressrelea.htm | 0001816431-26-000064 |
| Document: 0001816431-26-000064-index-headers.html | 0001816431-26-000064 |
| Document: 0001816431-26-000064-index.html | 0001816431-26-000064 |
| Document: 0001816431-26-000064.txt | 0001816431-26-000064 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 8-K | $1.31 | awaiting T+20 | — | $1.65 (+25.95%) |
Oct 15, 2026 12d ago | Press Release | $1.31 | awaiting T+20 | — | $1.65 (+25.95%) |
Oct 8, 2026 19d ago | 8-K | $1.53 | awaiting T+20 | — | $1.65 (+7.84%) |
Sep 28, 2026 28d ago | 8-K | $0.9581 $1.65 | ▲ +72.22% | ▲ +71.50% | $1.65 (+72.22%) |
Sep 23, 2026 4w ago | 144 | $0.7850 $1.15 | ▲ +46.50% | ▲ +46.92% | $1.65 (+110.19%) |
Sep 23, 2026 4w ago | 144 | $0.7850 $1.15 | ▲ +46.50% | ▲ +46.92% | $1.65 (+110.19%) |
Jun 24, 2026 17w ago | 144 | $0.8573 $0.7900 | ▼ −7.85% | ▼ −8.38% | $1.65 (+92.46%) |
Jun 24, 2026 17w ago | 144 | $0.8573 $0.7900 | ▼ −7.85% | ▼ −8.38% | $1.65 (+92.46%) |
Jun 24, 2026 17w ago | 8-K | $0.8573 $0.7900 | ▼ −7.85% | ▼ −8.38% | $1.65 (+92.46%) |
Mar 20, 2026 31w ago | Insider Cluster | $0.8450 $1.01 | ▲ +19.53% | ▲ +10.21% | $1.65 (+95.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers